ResMed Inc.

NYSE RMD

ResMed Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2024: USD 1.47 B

ResMed Inc. EBIT is USD 1.47 B for the Trailing 12 Months (TTM) ending September 30, 2024, a 27.94% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • ResMed Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 1.15 B, a 13.31% change year over year.
  • ResMed Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 1.01 B, a 7.48% change year over year.
  • ResMed Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 943.49 M, a 11.70% change year over year.
  • ResMed Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 844.66 M, a 40.87% change year over year.
Key data
Date EBIT EBITDA Net Income EPS (Diluted)
Market news
Loading...
NYSE: RMD

ResMed Inc.

CEO Mr. Michael J. Farrell BE, MBA, SM
IPO Date June 2, 1995
Location United States
Headquarters 9001 Spectrum Center Boulevard
Employees 9,980
Sector Health Care
Industries
Description

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Similar companies

COO

The Cooper Companies, Inc.

USD 89.11

-2.38%

TFX

Teleflex Incorporated

USD 179.17

0.35%

EMBC

Embecta Corp.

USD 20.10

0.95%

WST

West Pharmaceutical Services, Inc.

USD 328.96

-3.13%

STAA

STAAR Surgical Company

USD 21.65

-3.69%

BDX

Becton, Dickinson and Company

USD 235.80

-0.17%

MMSI

Merit Medical Systems, Inc.

USD 99.89

4.44%

ICUI

ICU Medical, Inc.

USD 161.08

1.85%

HOLX

Hologic, Inc.

USD 70.20

-0.13%

BAX

Baxter International Inc.

USD 30.62

0.39%

StockViz Staff

January 15, 2025

Any question? Send us an email